Results 141 to 150 of about 104,112 (336)

Can serum neuropeptide levels help diagnose pediatric migraine? A prospective case–control study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The objective of this study was to examine the serum levels of vasoactive neuropeptides (calcitonin gene‐related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP], which have been linked to the pathophysiology of migraine in adults) in pediatric ...
Sibğatullah Ali Orak   +8 more
wiley   +1 more source

Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants

open access: yesThe Turkish Journal of Pediatrics, 2010
Despite the relatively recent introduction of propranolol in the treatment of infantile hemangiomas, there can be little doubt of its efficacy. With regard to safety issues, there are no prior data for very low weight infants.
Ayşe Erbay   +10 more
doaj  

Effectiveness and tolerability of liraglutide as add‐on treatment in patients with obesity and high‐frequency or chronic migraine: A prospective pilot study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess whether glucagon‐like‐peptide‐1 receptor (GLP‐1R) agonists could serve as a novel prophylactic treatment for migraine in patients with obesity. Background Increased intracranial pressure (ICP) is speculated to play a role in migraine mechanisms, as chronic migraine and idiopathic intracranial hypertension without ...
Simone Braca   +6 more
wiley   +1 more source

A retrospective cohort study to evaluate the effectiveness and safety profile of occipital nerve blocks in the treatment of migraine during pregnancy

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Nearly 12% of Americans experience migraine, with 75% of that group represented by women aged 15–55 years, notably including peak childbearing years. This presents a therapeutic dilemma for pregnant patients, given that most medications for migraine range from unknown teratogenicity in human pregnancies, at best, to known
Liza Smirnoff   +4 more
wiley   +1 more source

Use of antimigraine medication before pregnancy and in the first trimester: A cross‐sectional study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Migraine is common among women, particularly during their reproductive years. There is limited research on the use of antimigraine medication before and during pregnancy. This study was undertaken to describe the use of antimigraine medication 3 months before pregnancy and in the first trimester among women with migraine ...
Stine Wieland   +7 more
wiley   +1 more source

Propranolol as ocular hypotensive agent. [PDF]

open access: bronze, 1967
C I Phillips, G. Howitt, D. J. Rowlands
openalex   +1 more source

Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE‐303 Open‐Label Study

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Etripamil is a fast‐acting intranasally self‐administered calcium‐channel blocker developed for termination of paroxysmal supraventricular tachycardia (PSVT). Prior studies have demonstrated safety and efficacy of etripamil for PSVT termination following an initial medically supervised test dose during sinus rhythm. NODE‐303 is an
James E. Ip   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy